EarningsQ3 2023 Earnings Report

Novartis (NVSN) Q3 2023 Earnings Report

0 Followers

MX:NVSN Q3 2023 EPS Results

Actual EPS$31.63

Consensus EPS$30.30

Beat/MissBeat by +$1.33

One Year Ago EPS$27.23

Actual Revenue$213.22B

Expected Revenue$225.69B

Beat/MissMissed by -$12.47B

YoY Revenue Growth-6.11%

QuarterQ3 2023

Date10/24/2023

TimeBefore Open

Conference CallTuesday, October 24, 2023

MX:NVSN Upcoming Earnings

Novartis's next earnings date is estimated for October 27, 2026, based on past reporting schedules.

MX:NVSN Q3 2023 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Oct 27, 2026	2026 (Q3)	41.23 / -	40.901	―
Jul 21, 2026	2026 (Q2)	39.48 / 43.81	43.991	-0.41% (-0.18)
Apr 28, 2026	2026 (Q1)	38.14 / 36.17	41.446	-12.72% (-5.27)
Feb 04, 2026	2025 (Q4)	36.05 / 36.90	35.993	2.53% (+0.91)
Oct 28, 2025	2025 (Q3)	41.32 / 40.90	37.447	9.22% (+3.45)
Jul 17, 2025	2025 (Q2)	42.74 / 43.99	35.811	22.84% (+8.18)
Apr 29, 2025	2025 (Q1)	38.43 / 41.45	32.721	26.67% (+8.73)
Jan 31, 2025	2024 (Q4)	32.81 / 35.99	27.813	29.41% (+8.18)
Oct 29, 2024	2024 (Q3)	35.23 / 37.45	31.63	18.39% (+5.82)
Jul 18, 2024	2024 (Q2)	33.63 / 35.81	31.521	13.61% (+4.29)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed